Arcellx (ACLX) Operating Leases (2022 - 2025)
Arcellx's (ACLX) quarterly Operating Leases came in at $44.3 million in Q4 2025, down 4.73% year-on-year from $46.5 million in Q4 2024, and little changed quarter-over-quarter from $44.3 million in Q3 2025.
Arcellx (ACLX) Operating Leases (2022 - 2025) Analysis & Trends
Arcellx's Operating Leases history runs 4 years deep, the most recent figure standing at $44.3 million for Q4 2025.
- On a quarterly basis, Operating Leases fell 4.73% year-over-year to $44.3 million in Q4 2025; TTM through Dec 2025 was $44.3 million, a 4.73% decrease from a year earlier, with the FY2025 full-year figure at $44.3 million, down 4.73% from the prior year.
- Operating Leases steadied at $44.3 million in Q4 2025 per ACLX's latest filing, from $44.3 million in the prior quarter.
- Across five years, Operating Leases topped out at $50.8 million in Q4 2023 and bottomed at $4.5 million in Q1 2022.
- The 4-year median for Operating Leases is $44.7 million (2025), against an average of $39.5 million.
- Across the five-year window, Operating Leases surged 610.98% in 2023 and dropped 8.46% in 2024, its largest moves.
- Year by year, Operating Leases stood at $31.3 million in 2022, then soared by 62.44% to $50.8 million in 2023, then retreated by 8.46% to $46.5 million in 2024, then dropped by 4.73% to $44.3 million in 2025.
- Per Business Quant, the three latest ACLX Operating Leases figures stand at $44.3 million (Q4 2025), $44.3 million (Q3 2025), and $45.1 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 44.34 Mn |
| Sep 30, 2025 | 44.32 Mn |
| Jun 30, 2025 | 45.10 Mn |
| Mar 31, 2025 | 45.83 Mn |
| Dec 31, 2024 | 46.54 Mn |
| Sep 30, 2024 | 47.21 Mn |
| Jun 30, 2024 | 47.87 Mn |
| Mar 31, 2024 | 47.69 Mn |
| Dec 31, 2023 | 50.84 Mn |
| Sep 30, 2023 | 48.10 Mn |
| Jun 30, 2023 | 40.64 Mn |
| Mar 31, 2023 | 31.99 Mn |
| Dec 31, 2022 | 31.30 Mn |
| Sep 30, 2022 | 29.21 Mn |
| Jun 30, 2022 | 27.20 Mn |
| Mar 31, 2022 | 4.50 Mn |